🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Denmark / NCT07247695
Recruiting Not applicable

Mechanisms Underlying the Placebo Effect in Both Histaminergic and Non-histaminergic Itch

NCT07247695 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2025-11-03
Last updated
2025-12-04

Condition(s) studied

ITCH

Investigational drug(s) / intervention(s)

HistamineCowhage

Histamine: To deliver histamine, standard allergy skin prick test (SPT) lancets are applied

Cowhage: The spicules will be manually inserted. Approximately 30-35 spicules are gently rubbed into a 1 cm diameter skin area on the forearm/face

Study summary

The study consists of one experimental session of approximately 1½ hours. The participant will fill in a series of questionnaires about how you perceive itch and pain, and about some traits of your personality, such as depression, anxiety and stress. Afterwards, two areas will be selected on each forearm of the subjects. The four areas will be treated with the same vehicle cream for 20 minutes, in order to test the placebo effect. At the end of the cream application, two areas will be randomly treated with histamine while cowhage will be applied on the other two areas. During the 10 minutes of the application of the pruritogens, itch and pain will be continuously monitored using a Visual Analog Scale.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy men and women * 18-60 years * Speak and understand English Exclusion Criteria: * Pregnancy or lactation * Drug addiction defined as any use of cannabis, opioids, or other drugs * Previous or current history of neurological, immunological, musculoskeletal, cardiac disorder or psychiatric diagnoses that may affect the results (e.g., neuropathy, muscular pain in the upper extremities, anxiety, depression, schizophrenia, etc.) * Moles, wounds, scars, or tattoos in the area to be treated or tested * Current use of medications that may affect the trial such as antihistamines and pain killers * Skin diseases * Consumption of alcohol or painkillers 24 hours before the study days and between these * Acute or chronic pain and itch * Participation in other trials within 1 week of study entry (4 weeks in the case of pharmaceutical studies) * Contraindications to capsaicin, including intolerance to chili or burns or wounds at the application site * The subject is assessed as unable to engage in the necessary cooperation required by the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Aalborg University Gistrup Denmark Recruiting

More Aalborg University trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07247695 on ClinicalTrials.gov ↗ ← All trials in Denmark